| NEO |
NeoGenomics Inc. Common Stock |
$16.6000 |
667120 |
|
NeoGenomics Completes Acquisition of Pathline |
| NK |
NantKwest Inc. Common Stock |
$30.5000 |
55510 |
|
ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch |
| VNDA |
Vanda Pharmaceuticals Inc. Common Stock |
$6.5300 |
469820 |
|
Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting |
| VTRS |
Viatris Inc. Common Stock |
$10.6500 |
4880000 |
|
Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims |
| AZYO |
Aziyo Biologics Inc. Class A Common Stock |
$6.4900 |
0 |
|
EluPro™ Named as 2025 Edison Award Winner |
| OPK |
OPKO Health Inc. Common Stock |
$2.0500 |
3120000 |
|
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program |
| SONN |
Sonnet BioTherapeutics Holdings Inc. Common Stock |
$0.3800 |
848070 |
|
Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose |
| GLSI |
Greenwich LifeSciences Inc. Common Stock |
$9.8900 |
13210 |
|
Greenwich LifeSciences Provides Global Update on FLAMINGO-01 |
| VIRI |
Virios Therapeutics Inc. Common Stock |
$2.1400 |
745920 |
|
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance |
| CRIS |
Curis Inc. Common Stock |
$0.7921 |
122230 |
|
Curis to Present at Upcoming Healthcare Conference in April |
| TECH |
Bio-Techne Corp Common Stock |
$89.4200 |
1610000 |
|
Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument |
| ALNY |
Alnylam Pharmaceuticals Inc. Common Stock |
$199.1700 |
305080 |
|
Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference |
| FBIO |
Fortress Biotech Inc. Common Stock |
$0.6099 |
5560000 |
|
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer |
| IDYA |
IDEAYA Biosciences Inc. Common Stock |
$21.6200 |
254010 |
|
IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events |
| INBX |
Inhibrx Inc. Common Stock |
$24.2000 |
201460 |
|
Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President |
| KPTI |
Karyopharm Therapeutics Inc. Common Stock |
$1.6600 |
2410000 |
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| ARTL |
Artelo Biosciences Inc. Common Stock |
$1.9600 |
13890 |
|
Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025 |
| BCLI |
Brainstorm Cell Therapeutics Inc. Common Stock |
$1.8400 |
92140 |
|
BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update |
| CABA |
Cabaletta Bio Inc. Common Stock |
$14.1400 |
208900 |
|
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update |
| COCP |
Cocrystal Pharma Inc. Common Stock |
$2.7300 |
19130 |
|
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs |
